| Serial Number | 79397084 |
| Word Mark | PHARMAGEND |
| Filing Date | Monday, March 18, 2024 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 11, 2025 |
| Registration Number | 7717933 |
| Registration Date | Tuesday, March 11, 2025 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, January 21, 2025 |
| Goods and Services | Technological research in the field of formulation development, scale-up batches, formulation refinement, drug delivery systems, and optimization of production processes; conducting technical project studies, namely, bioequivalence studies, clinical trial study design and regulatory compliance research in the pharmaceutical field; scientific laboratory services; providing scientific information, advice and consultancy relating to carbon offsetting; quality control for others; industrial inspection serialization of products, medical devices; quality assessment of pharmaceutical manufacturing processes, process validation, focusing on batch consistency, contamination control, impurity profiling and GMP compliance; biological research; medical and scientific research, namely, conducting clinical trials for others; medical research |
| Goods and Services | Immunological products for intravenous injections, namely for immune system support, such as vaccines, monoclonal antibodies (mAbs), Cytokines/Cytokine Inhibitors; tablets for medicines specifically diuretic, anti-fungal, digestive disorders, anti-inflammatory, antidiabetic, dementia tablets for treating common infections and chronic diseases; drinking water fused with electrolytes, salts, Hemodialysis solution, suitable for rehydration and maintenance therapy for medical purposes; medicinal ointments for treating skin conditions, such as dermatitis, wounds, or burns, offering antiseptic and healing properties; gelatin capsules sold empty for pharmaceuticals; slimming pills; medicines for human purposes for treating various ailments ranging from cough and cold medicines to cardiac disease; nutraceutical preparations for therapeutic or medical purposes for treating digestive disorders, vitamin deficiency, therapeutic dosage of vitamins; biochemical medicines for treating metabolic disorders, hormonal imbalances, autoimmune diseases, and rare genetic conditions, such as enzyme replacement therapies, peptide-based drugs, and nucleotide-based therapies; pharmaceutical preparations for treating heart diseases, asthma, obesity, diabetes, hypertension |
| Goods and Services | Custom assembling of materials for others, namely, multi-layer coated tablets, liquid filled hard gelatin capsules, bottle filling activities; providing information relating to material treatment; processing of metal surfaces using precision grinding techniques; irradiation of food; cryopreservation services; food and drink processing for others; processing of chemicals; sorting of waste and recyclable material; bookbinding; grinding |
| Goods and Services | Bases being chemical preparations of pharmaceutical drug product formulation, manufacturing, packing, testing and release to market; salts being chemical preparations for improved therapeutic actions, additional indication, drug product stability enhancement and bioavailability improvement in pharmaceutical products; cellulose derivatives being chemical preparations for use as excipients in drug formulation, providing controlled release and delayed release of drug enhancing bioavailability of drug product; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; animal extracts in the nature of from bovine source for use in pharmaceutical and nutraceutical manufacturing, particularly in dietary supplements and therapeutic drug products as well as nutritional products for the food industry; biological preparations for use in industry and science, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; plant extracts, other than essential oils, for use in the manufacture of pharmaceuticals; plant extracts, other than essential oils, for use in the manufacture of cosmetics |
| Goods and Services | Import-export agency services; business management consultancy; outsourcing services; business research; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 6, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 6, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 6, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 6, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 6, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PharmaGend Global Medical Services Pte Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | SG |
| Party Name | PharmaGend Global Medical Services Pte Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | SG |
| Party Name | PharmaGend Global Medical Services Pte Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | SG |
| Event Date | Event Description |
| Thursday, June 6, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, June 10, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, June 10, 2024 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, September 25, 2024 | ASSIGNED TO EXAMINER |
| Thursday, September 26, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, September 27, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, October 2, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, October 2, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, October 19, 2024 | REFUSAL PROCESSED BY IB |
| Sunday, December 22, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, December 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, December 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 27, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 10, 2025 | WITHDRAWN FROM ISSUE - OG REVIEW QUERY |
| Wednesday, January 15, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 21, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 21, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 11, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 11, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Thursday, June 12, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, September 24, 2025 | FINAL DISPOSITION PROCESSED |
| Thursday, September 25, 2025 | FINAL DISPOSITION NOTICE SENT TO IB |
| Saturday, October 18, 2025 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, November 5, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, November 5, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, November 22, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |